BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 26649818)

  • 1. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
    Wertz IE; Newton K; Seshasayee D; Kusam S; Lam C; Zhang J; Popovych N; Helgason E; Schoeffler A; Jeet S; Ramamoorthi N; Kategaya L; Newman RJ; Horikawa K; Dugger D; Sandoval W; Mukund S; Zindal A; Martin F; Quan C; Tom J; Fairbrother WJ; Townsend M; Warming S; DeVoss J; Liu J; Dueber E; Caplazi P; Lee WP; Goodnow CC; Balazs M; Yu K; Kolumam G; Dixit VM
    Nature; 2015 Dec; 528(7582):370-5. PubMed ID: 26649818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities.
    Martens A; Priem D; Hoste E; Vetters J; Rennen S; Catrysse L; Voet S; Deelen L; Sze M; Vikkula H; Slowicka K; Hochepied T; Iliaki K; Wullaert A; Janssens S; Lamkanfi M; Beyaert R; Armaka M; Bertrand MJM; van Loo G
    Nat Immunol; 2020 Apr; 21(4):381-387. PubMed ID: 32205881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
    Shembade N; Ma A; Harhaj EW
    Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
    Enesa K; Moll HP; Luong L; Ferran C; Evans PC
    FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.
    Lu TT; Onizawa M; Hammer GE; Turer EE; Yin Q; Damko E; Agelidis A; Shifrin N; Advincula R; Barrera J; Malynn BA; Wu H; Ma A
    Immunity; 2013 May; 38(5):896-905. PubMed ID: 23602765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1.
    Meng Z; Xu R; Xie L; Wu Y; He Q; Gao P; He X; Chen Q; Xie Q; Zhang J; Yang Q
    J Biol Chem; 2021 Jul; 297(1):100811. PubMed ID: 34023381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling.
    Bosanac I; Wertz IE; Pan B; Yu C; Kusam S; Lam C; Phu L; Phung Q; Maurer B; Arnott D; Kirkpatrick DS; Dixit VM; Hymowitz SG
    Mol Cell; 2010 Nov; 40(4):548-57. PubMed ID: 21095585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity.
    Evans PC; Ovaa H; Hamon M; Kilshaw PJ; Hamm S; Bauer S; Ploegh HL; Smith TS
    Biochem J; 2004 Mar; 378(Pt 3):727-34. PubMed ID: 14748687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
    De A; Dainichi T; Rathinam CV; Ghosh S
    EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
    Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
    Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct, noncatalytic mechanism of IKK inhibition by A20.
    Skaug B; Chen J; Du F; He J; Ma A; Chen ZJ
    Mol Cell; 2011 Nov; 44(4):559-71. PubMed ID: 22099304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
    Yamaguchi N; Yamaguchi N
    FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.
    Onizawa M; Oshima S; Schulze-Topphoff U; Oses-Prieto JA; Lu T; Tavares R; Prodhomme T; Duong B; Whang MI; Advincula R; Agelidis A; Barrera J; Wu H; Burlingame A; Malynn BA; Zamvil SS; Ma A
    Nat Immunol; 2015 Jun; 16(6):618-27. PubMed ID: 25939025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.
    Verhelst K; Carpentier I; Kreike M; Meloni L; Verstrepen L; Kensche T; Dikic I; Beyaert R
    EMBO J; 2012 Oct; 31(19):3845-55. PubMed ID: 23032186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biology. Turning off inflammation signaling.
    Sriskantharajah S; Ley SC
    Science; 2010 Feb; 327(5969):1093-4. PubMed ID: 20185718
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure of the A20 OTU domain and mechanistic insights into deubiquitination.
    Komander D; Barford D
    Biochem J; 2008 Jan; 409(1):77-85. PubMed ID: 17961127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice.
    Shrikhande GV; Scali ST; da Silva CG; Damrauer SM; Csizmadia E; Putheti P; Matthey M; Arjoon R; Patel R; Siracuse JJ; Maccariello ER; Andersen ND; Monahan T; Peterson C; Essayagh S; Studer P; Guedes RP; Kocher O; Usheva A; Veves A; Kaczmarek E; Ferran C
    PLoS One; 2010 Dec; 5(12):e14240. PubMed ID: 21151899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.